Benedicte Rouviere

Brest, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Journal: Postgraduate medicine

Published: July 06, 2026

Paraneoplastic ocular syndromes: a systematic review of epidemiology, diagnosis and outcomes (2010-2023).

Paraneoplastic ocular syndromes: a systematic review of epidemiology, diagnosis and outcomes (2010-2023).

Journal: Journal of ophthalmic inflammation and infection

Published: August 04, 2025

Artificial intelligence-based analysis of thrombotic and infectious risk factors in peripherally inserted central catheters (PICCs).

Artificial intelligence-based analysis of thrombotic and infectious risk factors in peripherally inserted central catheters (PICCs).

Journal: La Revue de medecine interne

Published: February 28, 2025

IgA vasculitis associated with chronic myelomonocytic leukemia.

IgA vasculitis associated with chronic myelomonocytic leukemia.

Journal: BMC rheumatology

Published: October 17, 2024

Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures.

Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures.

Journal: Annals of the rheumatic diseases

Published: April 08, 2024

History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis.

History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis.

Journal: RMD open

Published: August 18, 2023

Complement inhibitors: A global point of view

Complement inhibitors: A global point of view

Journal: La Revue de medecine interne

Published: March 23, 2022

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).

Journal: RMD open

Published: March 17, 2022

Assessing the robustness of clinical trials by estimating Jadad's score using artificial intelligence approaches.

Assessing the robustness of clinical trials by estimating Jadad's score using artificial intelligence approaches.

Journal: Computers in biology and medicine

Published: December 24, 2021

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.

Journal: American journal of ophthalmology

Published: October 24, 2021

Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.

Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.

Journal: Ophthalmology

Published: June 18, 2021

Multiple lesions on a PET-scan

Multiple lesions on a PET-scan

Journal: La Revue de medecine interne

Published: May 27, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026